Hartford Hospital's Institute of Living is the first medical facility in the state to offer the NeuroStar TMS Therapy system.

NeuroStar TMS is the first and only TMS Therapy® device cleared by the FDA for the treatment of patients who failed to benefit from prior antidepressant treatment. (TMS stands for “transcranial  magnetic stimulation.”)

NeuroStar TMS Therapy is a  non-systemic (does not circulate in the bloodstream throughout the body) and non-invasive (does not involve surgery) form of neuromodulation. It stimulates nerve cells in an area of the brain that is linked to depression by delivering highly focused MRI-strength magnetic pulses.

NEWS: Dr. Diefenbach was interviewed on WNPR regarding the Transcranial Magnetic Stimulation Research Program for Generalized Anxiety Disorder


NEWS: Hard To Treat Depression Patients Recover Completely With Repetitive Transcranial Magnetic Stimulation (rTMS)

Data from the first 'real-world' treatment audit presented at The Royal College of Psychiatrists' International Congress 2013 in Edinburgh show that 60% of patients with treatment-resistant depression achieved complete remission (patients report and show no symptoms) when treated with repetitive Transcranial Magnetic Stimulation (rTMS).
www.medicalnewstoday.com/releases/262968.php
Patients being treated by NeuroStar TMS Therapy do not require anesthesia or sedation and remain awake and alert. It is a 40-minute outpatient procedure that is prescribed by a psychiatrist and performed in a psychiatrist’s office. The treatment is typically administered daily for 4-6 weeks.


To Make an Appointment
Call (860) 545-7169


Learn More About TMS: